Sarda Proteins informs about outcome of board meeting
Sarda Proteins has informed that the meeting of the Board of Directors of the Company was held today on 30th April 2026 at 3.15 pm. The Board of Directors considered and approved the audited financial results for the quarter and financial year ended on 31st March 2026. The company has enclosed the standalone audited financial results along with Cash Flow Statement, Assets Liabilities Statement and Audit Report issued by the Statutory Auditor of the Company and Declaration signed by the Managing Director with respect to outcome of board meeting unmodified opinion on standalone audited financial results for the financial year ended on 31st March 2026. The meeting was concluded at 4.15 pm on the same day.
The above information is a part of company’s filings submitted to BSE.
